期刊文献+

基础肾功能与心脏再同步化治疗的效果 被引量:4

The clinical research of basic renal function and cardiac resynchronization therapy.
暂未订购
导出
摘要 目的探讨心力衰竭患者基础肾功能与心脏再同步化治疗(CRT)疗效的关系。方法 21例CRT患者按肾小球滤过率>60和<60 ml.min-1.1.73 m-2分为A、B组。术前评估患者的心功能、临床症状及超声参数。术后3个月、6个月再次评估上述指标。结果 A组术后心功能、临床症状、超声指标改善,B组有改善,但未达统计学意义。A组术后一周收缩压升高,而B组无变化,A组术后一周收缩压高于B组,舒张压两组术前、术后无差异。结论基础肾功能较好的患者,对CRT反应较好。 Objective To investigate the effects of cardiac resynchronization therapy (CRT) and basic renal function. Methods Twenty-one CRT recipients were studied. Before CRT, the clinical and eehocardigraphic evaluation was per- formed. At baseline, patients with glomerular filtration rate 〉 60 or 〈 60 ( ml min -1 . 1.73 m -2 ) were classified as group A or group B. At 3 months and 6 months after CRT, NYHA cardiac function classification, clinical and echocardigraphic evaluation was performed again. Results After CRT, the NYHA, the clinical symptoms and echocardigraphic index were improved of group A. The parameters of group B also changed, but didn't reach statistical difference. One week after CRT, the systolic blood pressure increased and was higher than that of group B; the diastolic blood pressure had no change between the two groups. Conclusion Patients of chronic heart failure with better basic renal function seem to have better response to CRT.
出处 《中国心脏起搏与心电生理杂志》 2012年第1期26-28,共3页 Chinese Journal of Cardiac Pacing and Electrophysiology
关键词 心血管病学 心脏再同步化治疗 肾功能 肾小球滤过率 收缩压 疗效 Cardiology Cardiac resynchronization therapy Basic renal function Glomerular filtration rate Systolic blood pressure Curative effect
  • 相关文献

参考文献2

二级参考文献27

  • 1华伟,王方正,朱丽,张澍,陈柯萍,牛红霞,陈新.117例双心室再同步起搏器植入术并发症分析[J].中华心律失常学杂志,2004,8(4):252-254. 被引量:34
  • 2杨西云,郭涛,韩明华.双心室起搏左心室导线植入失败原因分析[J].中华心律失常学杂志,2005,9(6):408-408. 被引量:8
  • 3Anh DJ,Chen HA,Eversull CS,et al.Early human experience with use of a deflectable fiberoptic endocardial visualization catheter to facilitate coronary sinus cannulation.Heart Rhythm,2006,3:875-878.
  • 4Pires LA,Abraham WT,Young JB,et al.Clinical predictors and timing of New York Heart Association class improvement with cardiac resynchronization therapy in patients with advanced chronic heart failure:results from the Multicenter InSync Randomized Clinical Evaluation (MIRACLE) and Multicenter InSync ICD Randomized Clinical Evaluation (MIRACLE-ICD) trials.Am Heart J,2006,151:837-843.
  • 5Auricchio A,Stellbrink C,Sack S,et al.The pacing therapies for congestive heart failure(PATH-CHF)study:rationale,design,and endpeints of a prospective randomized multicenter study[J].Am J Cardiol,1999,83:130D.
  • 6Huth C,Friedl A,Klein H,et al.Pacing therapies for congestive heart failure considering the results of the PATH-CHF study[J].Z Kardiol,2001,90(Suppl 1):10.
  • 7Cazeau S,Leclereq C,Lavergne T,et al.Effect of muhisite biventricular pacing in patients with heart failure and intreventricular conduetion delay.For the multisite stimulation in cardiomyopathies(MUSTIC)study investigators[J].N Engl J Med,2001,344:873.
  • 8Abraham WT,Fisher WG,Smith D,et al.Cardiac Resynchronization in Chronic Heart Failure.for the MIRACLE study group[J].N Engl J Med,2002,346:1845.
  • 9Young JB,Abraham WT,Smith A,et al.Combined cardiac resynchronization and implantable carclioversion defibrillation in advanced chronic heart failure.The MIRACLE ICD trial[J].JAMA,2003,289:2685.
  • 10Coletta AP,Louis AA,Clark AL,et al.Clinical trials update from the European Society of Cardiology:CARMEN,EARTH,OPTIMAAL,ACE,TEN-HMS,MAGIC,SOLVD-X and PATH-CHF Ⅱ[J].Eur J Heart Fail,2002,4(5):661.

共引文献25

同被引文献24

  • 1Aronson D, Krum H. Novel therapies in acute and chronic heart failure [ J ]. Pharmacol Ther, 2012,135 ( 1 ) : 1-17.
  • 2Hgye M, Forster T. Chronic heart failure with impaired left ventricular function systolic heart failure [J]. Orv Hetil, 2012, 153(51 ) :2021-2029.
  • 3Sipahi I, Chou JC, Hyden M, et al. Effect of QRS morphology on clinical event reduction with cardiac resynchronization therapy: Meta-analysis of randomized controlled trials I J]. Am Heart J, 2012,163(2) :260-267.
  • 4Gabrielli L, Sitges M, Mont L. Assessing reverse remodeling in heart failure patients treated with cardiac resynchronization therapy and its impact on prognosis [J]. Expert Rev Cardiovasc Ther, 2012,10( 11 ) : 1437-1448.
  • 5St hlberg M1, Lund LH, Zabarovskaja S, et al. Cardiac resynchronization therapy: a breakthrough in heart failure management [J]. J Intern Med, 2012,272(4) : 330-343.
  • 6Lilli A, Ricciardi G, Cristina M, et al. Cardiac resynchronization therapy: gender relate differences in left ventricular reverse remodeling [J]. PACE, 2007,30( 11 ) : 1349-1355.
  • 7Bleeker GB, Schalij M J, Boersma E, et al. Does a gender difference in effective to cardiac resynchronization therapy exist [J]. PACE, 2005,28(12) : 1271-1275.
  • 8Wikstrom Q, Blomstrom-Lundqcist C, Andren B, et al. The effects of aetiology on outcome in patients treated with cardiac resynchronization therapy in the CARE-HF trial [J]. Eur Heart J, 2009,30(7) :782-785.
  • 9Nesser H.I, Mor-Avi V, Gorissen W, et al. Quantification of left ventricular volumes using three-dimensional echocardiographic speckle tracking: comparison with MRI [J]. Eur Heart J, 2009, 30(13) : 1565-1573.
  • 10Seo Y, Ishizu T, Enomoto Y, et al. Endocardial Surface Area Tracking for Assessment of Regional LV Wall Deformation With 3D Speckle Tracking Imaging [J]. JACC Cardiovasc Imaging, 2011,4(4) :358-365.

引证文献4

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部